{"product_id":"biomarkers-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","title":"Biomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028","description":"\u003cp\u003eBiomarkers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028\u003c\/p\u003e\n\n\u003cp\u003eMarket Overview:\u003c\/p\u003e\n\n\u003cp\u003eThe global biomarkers market size reached US$ 68.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 139.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028.\u003c\/p\u003e\n\n\u003cp\u003eBiomarkers, also known as biological markers, are molecules or genes that are used as indicators of the health or status of an organ, tissue, or cell. In addition to blood and bodily fluids, biomarkers are also found in tissues. In the discovery and development of new drugs, biomarkers are used for risk assessment, molecular diagnostics, disease diagnosis, DNA fingerprinting, and eliminating complexity. As a result, they play a crucial role in improving the drug development process, drug validation and testing, sample preparation and assay development. Biomarkers are often integrated with key imaging technologies that can provide clear images of oncology tumors and other problems while also eliminating the possibility of radiation exposure during CT scans and MRI scans.\u003c\/p\u003e\n\n\u003cp\u003eBiomarkers Market Trends:\u003c\/p\u003e\n\n\u003cp\u003eThe market is majorly driven by the rising incidences of numerous chronic diseases among the masses, particularly in the geriatric population. In addition to this, the increasing implementation of biomarkers in infectious disease diagnosis is propelling the market. Moreover, continual developments in biomarker-based diagnostics, such as biomarker signatures resulting in faster drug development, non-invasive testing, and early diagnosis, are also creating a positive market outlook. In line with this, the rapid utilization of biomarkers in the development of companion diagnostics to identify drug target molecules is providing an impetus to the market. Also, the escalating demand for personalized medicine, along with a paradigm shift toward biomarker studies from conventional pathophysiology and epidemiology methods, is fueling the market. Furthermore, a considerable rise in the number of contract research organizations facilitating cost-efficient clinical trials are creating a positive market outlook. Some of the other factors contributing to the market include extensive research and development (R\u0026amp;D) activities and the increasing medical expenditure.\u003c\/p\u003e\n\n\u003cp\u003eKey Market Segmentation:\u003c\/p\u003e\n\n\u003cp\u003eIMARC Group provides an analysis of the key trends in each sub-segment of the global biomarkers market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, type, disease, application and end user.\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Product:\u003c\/p\u003e\n\n\u003cp\u003eConsumables\u003cbr\u003e\nServices\u003cbr\u003e\nSoftware\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Type:\u003c\/p\u003e\n\n\u003cp\u003eEfficacy Biomarkers\u003cbr\u003e\nSafety Biomarkers\u003cbr\u003e\nValidation Biomarkers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Disease:\u003c\/p\u003e\n\n\u003cp\u003eCancer\u003cbr\u003e\nCardiovascular Disorders\u003cbr\u003e\nNeurological Disorders\u003cbr\u003e\nImmunological Disorders\u003cbr\u003e\nRenal Disorders\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Application:\u003c\/p\u003e\n\n\u003cp\u003eDiagnostics\u003cbr\u003e\nDrug Discovery and Development\u003cbr\u003e\nPersonalized Medicine\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by End User:\u003c\/p\u003e\n\n\u003cp\u003ePharmaceutical and Biotechnology Companies\u003cbr\u003e\nDiagnostic and Research Laboratories\u003cbr\u003e\nHospitals and Specialty Clinics\u003cbr\u003e\nOthers\u003c\/p\u003e\n\n\u003cp\u003eBreakup by Region:\u003c\/p\u003e\n\n\u003cp\u003eNorth America\u003cbr\u003e\nUnited States\u003cbr\u003e\nCanada\u003cbr\u003e\nAsia-Pacific\u003cbr\u003e\nChina\u003cbr\u003e\nJapan\u003cbr\u003e\nIndia\u003cbr\u003e\nSouth Korea\u003cbr\u003e\nAustralia\u003cbr\u003e\nIndonesia\u003cbr\u003e\nOthers\u003cbr\u003e\nEurope\u003cbr\u003e\nGermany\u003cbr\u003e\nFrance\u003cbr\u003e\nUnited Kingdom\u003cbr\u003e\nItaly\u003cbr\u003e\nSpain\u003cbr\u003e\nRussia\u003cbr\u003e\nOthers\u003cbr\u003e\nLatin America\u003cbr\u003e\nBrazil\u003cbr\u003e\nMexico\u003cbr\u003e\nOthers\u003cbr\u003e\nMiddle East and Africa\u003c\/p\u003e\n\n\u003cp\u003eCompetitive Landscape:\u003c\/p\u003e\n\n\u003cp\u003eThe competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Epigenomics AG, Eurofins Scientific SE, Merck KGaA, Perkinelmer Inc., Qiagen N.V, Quanterix Corporation, SphingoTec GmbH and Thermo Fisher Scientific Inc.\u003c\/p\u003e\n\n\u003cp\u003eKey Questions Answered in This Report\u003cbr\u003e\n1. What was the size of the global biomarkers market in 2022?\u003cbr\u003e\n2. What is the expected growth rate of the global biomarkers market during 2023-2028?\u003cbr\u003e\n3. What are the key factors driving the global biomarkers market?\u003cbr\u003e\n4. What has been the impact of COVID-19 on the global biomarkers market?\u003cbr\u003e\n5. What is the breakup of the global biomarkers market based on the product?\u003cbr\u003e\n6. What is the breakup of the global biomarkers market based on the type?\u003cbr\u003e\n7. What is the breakup of the global biomarkers market based on disease?\u003cbr\u003e\n8. What is the breakup of the global biomarkers market based on the application?\u003cbr\u003e\n9. What is the breakup of the global biomarkers market based on the end user?\u003cbr\u003e\n10. What are the key regions in the global biomarkers market?\u003cbr\u003e\n11. Who are the key players\/companies in the global biomarkers market?\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"February, 2023 \/ 147 Pages \/ MCW16227388","offer_id":47645953589554,"sku":null,"price":3104.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/biomarkers-market-global-industry-trends-share-size-growth-opportunity-and-forecast-2023-2028","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}